The University of La Sabana is a Colombian private higher education institution founded in 1979. It is located in the municipality of Chía, 7 km north of Bogotá. The university has been given the High Quality Institutional Accreditation by the Ministry of National Education.

During the past decade, Universidad de La Sabana conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universidad de La Sabana" #1 sponsor was "Fundación Neumologica Colombiana" with 3 trials, followed by "Tecnoquimicas" with 2 trials sponsored, "University of Michigan" with 2 trials sponsored, "UMC Utrecht" with 1 trials sponsored and "Universidad de la Sabana" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universidad de La Sabana" #1 collaborator was "Universidad de la Sabana" with 4 trials as a collaborator, "Australian and New Zealand Intensive Care Research Centre" with 1 trials as a collaborator, "Berry Consultants" with 1 trials as a collaborator, "Clínica Universidad de La Sabana" with 1 trials as a collaborator and "Foundation for Research in Nutrition and Health (FINUSAD)" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Universidad de La Sabana" are "Healthy" (2 trials), "25-hydroxyvitamin D Serum Concentrations" (1 trials), "Assessment, Self" (1 trials), "Behavior Problem" (1 trials) and "Child Growth" (1 trials). Many other conditions were trialed in "Universidad de La Sabana" in a lesser frequency.

Most popular intervention types in "Universidad de La Sabana" are "Drug" (3 trials), "Other" (3 trials), "Device" (2 trials), "Biological" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "ARB + DMX-200" (1 trials), "Amoxicillin-clavulanate" (1 trials), "Anakinra" (1 trials), "Angiotensin Receptor Blockers" (1 trials) and "Angiotensin converting enzyme inhibitor" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universidad de La Sabana" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Universidad de La Sabana". 1 are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Universidad de La Sabana, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universidad de La Sabana, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".